Overview

Safety and Efficacy of 6% Hydroxyethyl Starch (HES) Solution Versus an Electrolyte Solution in Patients Undergoing Elective Abdominal Surgery

Status:
Recruiting

Trial end date:
2020-06-17

Target enrollment:

Participant gender:

Summary

The aim of the study is to investigate the safety of a 6% HES (Hydroxyethyl Starch) solution (Volulyte 6%) versus an electrolyte solution (Ionolyte) in patients undergoing elective abdominal surgery.

Phase:

Phase 4

Details

Lead Sponsor:

B. Braun Melsungen AG

Collaborators:

European Society of Anaesthesiology
Fresenius Kabi

Treatments:

Hydroxyethyl Starch Derivatives
Pharmaceutical Solutions